Majority Whip Clyburn Hails Passage of H.R. 3 Legislation to Lower Drug Costs

Majority Whip Clyburn Hails Passage of H.R. 3 Legislation to Lower Drug Costs

by January 6, 2020

Also Includes Clyburn Effort to Expand Community Health Centers

WASHINGTON, D.C. – U.S. House Majority Whip James E. Clyburn hailed House passage of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act. This landmark legislation gives Medicare the power to negotiate directly with drug companies and extends those lower prices to Americans with private insurance too.

“This is an important step toward providing American consumers more accessible and affordable prescription drugs,” Congressman Clyburn said. “In the United States, our drug prices are nearly four times higher than in similar countries, and this legislation will provide real price reductions that will put significant money back in the pocket of consumers.”

Negotiating lower prescription drug prices has the added benefit of cost savings to American taxpayers. A portion of those savings will be reinvested in the National Institutes of Health to research new cures and treatments. Cost savings will also support an expansion of Medicare benefits to cover dental, vision, and hearing needs and sets a $2,000 out-of-pocket limit on prescription drug costs for those on Medicare.

In addition, cost savings will be used to fund provisions of Congressman Clyburn’s H.R. 1943 – Community Health Center and Primary Care Workforce Expansion Act of 2019. H.R. 3 will provide a $10 billion funding boost to community health centers, which serve 28 million Americans in communities across the United States, including over 350,000 veterans, 8 million children, and 1.4 million homeless patients.

This $10 billion includes $5 billion for capital improvements and construction to expand the footprint of community health centers and an additional $5 billion in funding over the next five years for community health center grants, allowing them to serve more people, including Americans living in rural areas, where half of the Centers are located.

“Providing robust funding to build on the success of community health centers is critically important to providing quality health care in hard-to-reach communities,” Congressman Clyburn continued. “In my district alone, where three rural hospitals have closed, there are eight federally-funded community health centers working to serve almost 190,000 patients.”

H.R. 3 passed the House on a bipartisan vote, 230-192, and was sent to the Senate for consideration.


Excerpt:
“This is an important step toward providing American consumers more accessible and affordable prescription drugs,” Congressman Clyburn said. “In the United States, our drug prices are nearly four times higher than in similar countries, and this legislation will provide real price reductions that will put significant money back in the pocket of consumers.”

Photo Caption:
U.S. House Majority Whip James E. Clyburn hailed House passage of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act.

Website Tags and Keywords:
WASHINGTON D.C., U.S. House Majority Whip James E. Clyburn, H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, landmark legislation, Medicare, the power to drug companies, Americans with private insurance, American consumers, accessible and affordable prescription drugs, United States, American taxpayers, National Institutes of Health, research new cures, treatments, Medicare benefits, dental, vision, hearing needs, $2000 out-of-pocket limit, Congressman Clyburn’s H.R. 1943, Community Health Center and Primary Care Workforce Expansion Act of 2019, $10 billion funding boost to community health centers, community health centers, hard-to-reach communities

Hashtags:
@WhipClyburn @NNPA_BlackPress @CDC #ElijahECummingsLowerDrugCostsNowAct

Print Friendly, PDF & Email